148 related articles for article (PubMed ID: 18030515)
1. The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate.
Scarpa R; Peluso R; Atteno M; Manguso F; Spanò A; Iervolino S; Di Minno MN; Costa L; Del Puente A
Clin Rheumatol; 2008 Jul; 27(7):823-6. PubMed ID: 18030515
[TBL] [Abstract][Full Text] [Related]
2. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
El Miedany Y; Youssef SS; El Gaafary M
J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate in Early Chikungunya Arthritis: A 6 Month Randomized Controlled Open-label Trial.
Adarsh MB; Sharma SK; Dwivedi P; Singh MP; Dhir V; Jain S
Curr Rheumatol Rev; 2020; 16(4):319-323. PubMed ID: 31858912
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of disease modifying anti-rheumatic drugs in rheumatoid arthritis in local patients of Karachi.
Baig MS; Humail SM; Zaidi SI; Noor S; Bano S; Rehman S; Fawwad A
Pak J Biol Sci; 2009 Feb; 12(4):339-45. PubMed ID: 19579967
[TBL] [Abstract][Full Text] [Related]
5. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
Rau R; Schleusser B; Herborn G; Karger T
J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
[TBL] [Abstract][Full Text] [Related]
6. A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis.
Lerndal T; Svensson B
Rheumatology (Oxford); 2000 Mar; 39(3):316-20. PubMed ID: 10788542
[TBL] [Abstract][Full Text] [Related]
7. Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A.
Gül U; Gönül M; Kiliç A; Erdem R; Cakmak SK; Gündüz H
Clin Ther; 2006 Feb; 28(2):251-4. PubMed ID: 16678646
[TBL] [Abstract][Full Text] [Related]
8. Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial.
Karanikolas GN; Koukli EM; Katsalira A; Arida A; Petrou D; Komninou E; Fragiadaki K; Zacharioudaki A; Lasithiotakis I; Giavri E; Vaiopoulos G; Sfikakis PP
J Rheumatol; 2011 Nov; 38(11):2466-74. PubMed ID: 21885499
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study.
Spadaro A; Riccieri V; Sili-Scavalli A; Sensi F; Taccari E; Zoppini A
Clin Exp Rheumatol; 1995; 13(5):589-93. PubMed ID: 8575136
[TBL] [Abstract][Full Text] [Related]
10. [A clinical study of leflunomide and methotrexate therapy in psoriatic arthritis].
Zhang GL; Huang F; Zhang JL; Li XF
Zhonghua Nei Ke Za Zhi; 2009 Jul; 48(7):570-4. PubMed ID: 19957798
[TBL] [Abstract][Full Text] [Related]
11. The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study.
Heiberg MS; Kaufmann C; Rødevand E; Mikkelsen K; Koldingsnes W; Mowinckel P; Kvien TK
Ann Rheum Dis; 2007 Aug; 66(8):1038-42. PubMed ID: 17213251
[TBL] [Abstract][Full Text] [Related]
12. Results of one-year treat-to-target strategy in early psoriatic arthritis: data of an open-label REMARCA study.
Korotaeva TV; Loginova EY; Getiya TS; Nasonov EL
Ter Arkh; 2018 May; 90(5):22-29. PubMed ID: 30701886
[TBL] [Abstract][Full Text] [Related]
13. A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis.
Fraser AD; van Kuijk AW; Westhovens R; Karim Z; Wakefield R; Gerards AH; Landewé R; Steinfeld SD; Emery P; Dijkmans BA; Veale DJ
Ann Rheum Dis; 2005 Jun; 64(6):859-64. PubMed ID: 15528283
[TBL] [Abstract][Full Text] [Related]
14. A 36 month comparative trial of methotrexate and gold sodium thiomalate in the treatment of early active and erosive rheumatoid arthritis.
Menninger H; Herborn G; Sander O; Blechschmidt J; Rau R
Br J Rheumatol; 1998 Oct; 37(10):1060-8. PubMed ID: 9825744
[TBL] [Abstract][Full Text] [Related]
15. Effect of interleukin-17A inhibitor in Japanese patients with psoriatic arthritis compared with tumor necrosis factor-alpha inhibitor.
Izumiyama T; Mori Y; Oizumi I; Hamada S; Kurishima H; Terui H; Omori-Shimada R; Yamasaki K; Itoi E
J Orthop Surg (Hong Kong); 2021; 29(2):23094990211012286. PubMed ID: 33938296
[TBL] [Abstract][Full Text] [Related]
16. Influenza vaccine with adjuvant on disease activity in psoriatic arthritis patients under anti-TNF-α therapy.
Caso F; Ramonda R; Del Puente A; Darda MA; Cantarini L; Peluso R; Esposito C; Ortolan A; Fiocco U; Punzi L; Scarpa R; Costa L
Clin Exp Rheumatol; 2016; 34(3):507-12. PubMed ID: 26967009
[TBL] [Abstract][Full Text] [Related]
17. Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic Arthritis.
Sheane BJ; Thavaneswaran A; Gladman DD; Chandran V
J Rheumatol; 2016 Sep; 43(9):1718-23. PubMed ID: 27422895
[TBL] [Abstract][Full Text] [Related]
18. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
[TBL] [Abstract][Full Text] [Related]
20. Combination DMARD treatment with parenteral gold and methotrexate.
Rau R
Clin Exp Rheumatol; 1999; 17(6 Suppl 18):S83-90. PubMed ID: 10589364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
